All ProductsDisplaying Products by Catalog Number (4700 - 4799)
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800
| Cat. No. | Product Name / Activity |
|---|---|
| 4701 | EC 144 |
| High affinity, potent and selective Hsp90 inhibitor | |
| 4703 | 3-Deazaneplanocin A hydrochloride |
| EZH2 histone methyltransferase inhibitor | |
| 4708 | TC LPA5 4 |
| LPA5 receptor antagonist | |
| 4709 | RuBi GABA trimethylphosphine |
| Caged GABA; inhibits neural activity | |
| 4710 | PF 06465469 |
| Potent ITK inhibitor; also inhibits BTK | |
| 4712 | Salmeterol xinafoate |
| Long-acting β2 agonist; bronchodilator | |
| 4715 | JZL 195 |
| Dual FAAH and MAGL inhibitor | |
| 4716 | A 967079 |
| Selective TRPA1 channel blocker | |
| 4719 | VU 0463271 |
| Potent and selective KCC2 inhibitor | |
| 4720 | Entacapone |
| Potent COMT inhibitor; blocks α-synuclein aggregation | |
| 4723 | T2AA |
| PCNA inhibitor | |
| 4724 | BTT 3033 |
| Selective inhibitor of integrin α2β1 | |
| 4726 | CTA 056 |
| ITK inhibitor | |
| 4727 | GS 6201 |
| Selective A2B antagonist | |
| 4730 | PPY A |
| Potent inhibitor of Abl T315l mutant and wild-type Abl kinases | |
| 4731 | KY 02111 |
| Inhibits canonical Wnt signaling. Promotes differentiation of human ESCs and iPSCs into cardiomyocytes | |
| 4732 | ML 204 |
| Selective TRPC4 inhibitor | |
| 4735 | Quetiapine hemifumarate |
| 5-HT2 antagonist; also D2 antagonist; atypical antipsychotic | |
| 4736 | WIN 18446 |
| ALDH1A2 inhibitor | |
| 4737 | CDDO Im |
| Nrf2 signaling activator | |
| 4741 | Gadolinium chloride |
| Stretch-activated calcium channel blocker; calcium-sensing receptor agonist | |
| 4745 | LIMKi 3 |
| Potent LIM kinase inhibitor; antitumor | |
| 4746 | ML SA1 |
| Activator of TRPML channels | |
| 4748 | ML 221 |
| Apelin antagonist | |
| 4751 | FSLLRY-NH2 |
| PAR2 peptide antagonist | |
| 4754 | AK 7 |
| Selective SIRT2 inhibitor; brain penetrant | |
| 4758 | Bromosporine |
| Broad spectrum bromodomain inhibitor | |
| 4759 | G-36 |
| Selective GPER antagonist | |
| 4763 | Pyridostatin pentahydrochloride |
| Stabilizes G-quadruplexes; induces DNA damage and cell cycle arrest | |
| 4767 | WAY 316606 hydrochloride |
| Secreted Frizzled-related protein-1 (sFRP-1) inhibitor; increases Wnt signaling | |
| 4773 | ESI 09 |
| Epac inhibitor | |
| 4774 | BMS 536924 |
| Dual IR/IGF1R inhibitor | |
| 4775 | SD 2590 hydrochloride |
| Potent MMP inhibitor | |
| 4776 | BIRT 377 |
| Potent negative allosteric modulator of LFA-1 | |
| 4777 | ML 277 |
| Selective KV7.1 (KCNQ1) potassium channel activator; augments IKs current | |
| 4778 | BETP |
| Positive allosteric modulator of GLP-1 receptors | |
| 4779 | GRI 977143 |
| Selective LPA2 receptor non-lipid agonist | |
| 4781 | ANA 12 |
| TrkB receptor antagonist | |
| 4782 | Org 25543 hydrochloride |
| Potent and selective GlyT2 inhibitor | |
| 4784 | Edaglitazone |
| Potent and selective PPARγ agonist; antidiabetic | |
| 4786 | PD 0332991 isethionate |
| Potent cdk4 and cdk6 inhibitor; brain penetrant | |
| 4788 | NS 11021 |
| KCa1.1 (BK) channel activator | |
| 4791 | Candesartan |
| AT1 antagonist | |
| 4793 | CE3F4 |
| Noncompetitive Epac1 inhibitor | |
| 4795 | Galloflavin |
| Lactate dehydrogenase inhibitor; impairs aerobic glycolysis | |
| 4796 | Escitalopram oxalate |
| Selective serotonin reuptake inhibitor (SSRI) | |
| 4798 | (S)-Duloxetine hydrochloride |
| Potent 5-HT and NA reuptake inhibitor (SNRI); also blocks dopamine reuptake |